Tessan is reshaping how health care is accessed and delivered, leveraging continuous engagement in health services to improve patient outcomes. Founded in 2018 and headquartered in France, the company operates within the Health Care, Medical Devices, and Pharmaceutical industries.
The company's comprehensive approach focuses on early detection, immediate consultation, and ongoing patient follow-up. Tessan's services are readily accessible both in pharmacies and at home, supported by its status as an accredited teleconsultation entity by the French Ministry of Health.
With over 1,600 pharmacies and health centers equipped, 500 medical professionals engaged, and more than 700,000 consultations anticipated by 2025, Tessan plays a pivotal role in integrating telehealth into daily care routines. Since 2018, they've assisted 1.5 million patients, showcasing their capacity to meet diverse healthcare needs.
Though specific recent investment details are not disclosed, Tessan's innovative model and substantial reach make it an attractive proposition for future investment opportunities.